Our lab is recruiting both a postdoc and research technician to start in May/June! If you know anyone interested in investigating mechanisms of metastasis and immune suppression in cancer through developing innovative mouse models and studying senescence, please spread the word!

Congress has completed their work on FY26 spending bills and we’re so excited to share that because of you and your fellow PanCAN advocates, increases for #pancreaticcancer research were included. This is a major win! 👏 When negotiations for this fiscal year began, proposals included cuts to pancreatic cancer research — you refused to stay silent. You emailed, called, shared your stories and showed up again and again to make it clear that patients and families cannot afford to lose momentum. Thank you for capturing Congress’ attention and making them understand that new discoveries are on the horizon — they just need funding. Lawmakers ultimately rejected proposed cuts and prioritized patients, passing full-year spending bills that include meaningful increases for cancer research, with $47.2 billion allocated for the National Institutes of Health and $7.352 billion allocated for the National Cancer Institute. Also included was the Medicare Multi-Cancer Early Detection Act. This legislation allows the Centers for Medicare and Medicaid Services (CMS) to create a pathway for coverage for multi-cancer tests upon FDA-approval — early detection tests designed to screen for multiple cancer types including pancreatic cancer. And the power of PanCAN advocates is on full display as Congress reinstated the dedicated Pancreatic Cancer Research Program (PCARP) – previously eliminated – with $20 million in funding! This is the first increase for PCARP since FY21 and the most funding the program has ever received. Progress is powered by passionate people like you. Thank you for changing the story of pancreatic cancer for patients and families. 💜 For more, visit 🔗 pcan.at/advocacy.